Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Documenti analoghi

• Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia
  di: Georgia McCaughan, et al.
  Pubblicazione: (2025)
• Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma
  di: Rajshekhar Chakraborty, et al.
  Pubblicazione: (2024)
• D‐VMP elicits clinical benefits in transplant‐ineligible patients with newly diagnosed multiple myeloma
  di: Mary Beth Nierengarten
  Pubblicazione: (2025)
• The importance of autologous stem cell transplantation in improving outcomes in newly diagnosed patients with multiple myeloma
  di: Morie A. Gertz
  Pubblicazione: (2024)
• Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma
  di: Heinz Ludwig, et al.
  Pubblicazione: (2024)